In conclusion, we have described the unexpected finding that agonistic monoclonal antibodies against CD40 can successfully control chronic autoimmune inflammatory processes, indicating their ...

In little more than five years, German biotechnology company YUMAB (a phonetic play on HUMAB (human monoclonal ... antibody discovery and development strategies to optimize the process from ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...